You have to be signed in to use this resource.
Spring 2026 COVID-19 vaccination campaign: Comirnaty LP.8.1 30 micrograms/dose mRNA vaccine: assessment
Certificate available: complete this course to be awarded a certificate
This session will present you with a series of multiple-choice questions to test your knowledge of the Pfizer BioNTech Comirnaty LP.8.1 30 micrograms/dose COVID-19 vaccine and its use during the spring 2026 vaccination campaign. Once you have answered a question, please select the 'Save Answer' button. Then select the 'Next' button to move on to the next question. You will not be able to change your answer once you have clicked on the 'submit' button. Please ensure that you finalise your answers to all the questions before submitting them for marking as you will not be able to change them once they have been submitted and marked.
Resource details
| Contributed by: | COVID-19 Vaccination |
| Authored by: |
|
| Licence: | © All rights reserved More information on licences |
| First contributed: | 17 March 2026 |
| Audience access level: | General user |
Report an issue with this resource
You may report a resource, for example, if there is an issue with copyright infringement, breach of personal data, factual inaccuracies, typing errors or safety concerns. The type of issue will determine whether the resource is immediately removed from the platform or if the contributor is asked to make amendments. You can report a resource from the resource information page or by contacting the Learning Hub support team.
You can contact the Learning Hub support team by completing the support form or if you have a general enquiry you can email enquiries@learninghub.nhs.uk.